¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"indirect nuclear division"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • indirect fluorescent antibody test
    °£Á¢Çü±¤Ç×ü°Ë»ç
  • indirect gonioscopy
    °£Á¢Àü¹æ°¢°æ°Ë»ç, °£Á¢¾Õ¹æ°¢º¸°³°Ë»ç
  • indirect hemagglutination
    °£Á¢ÀûÇ÷±¸ÀÀÁý
  • indirect immunodiffusion
    °£Á¢¸é¿ªÈ®»ê
  • indirect immunofluorescence reaction
    °£Á¢¸é¿ªÇü±¤¹ÝÀÀ
  • indirect infection
    °£Á¢°¨¿°
  • indirect inguinal hernia
    °£Á¢»ô±¼Å»Àå, °£Á¢¼­ÇýÅ»Àå
  • indirect latex agglutination
    °£Á¢¶óÅØ½ºÀÀÁý¹ÝÀÀ
  • indirect ophthalmoscope
    µµ»ó°Ë¾È°æ, °Å²Ü´«º¸°³
  • indirect proof
    °£Á¢Áõ¸í(¹ý)
  • indirect retainer
    °£Á¢À¯ÁöÀåÄ¡
  • autonomous nuclear family
    ÀÚÀ²ÇÙ°¡Á·
  • nuclear bag
    ÇÙÁÖ¸Ó´Ï
  • nuclear bag fiber
    ÇÙÁָӴϼ¶À¯, ÇÙÁָӴϱÙ(À°)¼¼Æ÷
  • nuclear bombardment
    ÇÙÃæ°Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • indirect immunodiffusion
    °£Á¢¸é¿ªÈ®»ê
  • indirect infection
    °£Á¢°¨¿°
  • indirect ophthalmoscope
    µµ»ó°Ë¾È°æ, °Å²Ü´«º¸°³
  • indirect proof
    °£Á¢Áõ¸í(¹ý)
  • indirect retainer
    °£Á¢À¯ÁöÀåÄ¡
  • indirect transfusion
    °£Á¢¼öÇ÷
  • indirect antiglobulin test
    °£Á¢Çױ۷κҸ°°Ë»ç
  • indirect direct method
    °£Á¢Á÷Á¢¹ý
  • indirect fluorescent antibody technique
    °£Á¢Çü±¤Ç×ü¹ý
  • indirect fluorescent antibody test
    °£Á¢Çü±¤Ç×ü°Ë»ç
  • indirect immunofluorescence reaction
    °£Á¢¸é¿ªÇü±¤¹ÝÀÀ
  • autonomous nuclear family
    ÀÚÀ²ÇÙ°¡Á·
  • nuclear bag
    ÇÙÁÖ¸Ó´Ï
  • nuclear bombardment
    ÇÙÃæ°Ý
  • nuclear cardiology
    ½ÉÀåÇÙÀÇÇÐ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inner nuclear layer
    ³»°ú¸³Ãþ(Ò®öµ), ¼ÓÇÙÃþ.
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ.
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ ÇÙ¼º ¾È±Ù¸¶ºñ(òäú¼àõ ú·àõ äÑÐÉØ¦Ýö)
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ
  • agglutination, indirect
    °£Á¢ÀÀÁý¹ý
  • antiglobulin test, indirect
    °£Á¢Çױ۷κҸ° °Ë»ç
  • hemagglutination, indirect
    °£Á¢Ç÷±¸ÀÀÁý¹ý
  • indirect
    °£Á¢
  • indirect Coombs test
    °£Á¢Äñ½º°Ë»ç
  • indirect action
    °£Á¢ÀÛ¿ë.
  • indirect action
    °£Á¢ÀÛ¿ë
  • indirect agglutination
    °£Á¢ÀÀÁý(¹ÝÀÀ).
  • indirect analysis
    °£Á¢ºÐ¼®.
  • indirect antiglobulin test
    °£Á¢Çױ۷κҸ°°Ë»ç
  • indirect antiglobulin test
    °£Á¢Çױ۷κҸ°½ÃÇè
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • equal division
    µ¿¼öºÐ¿­
  • equational division
    µî¼öºÐ¿­.
  • equatorial division
    ÀûµµºÐ¿­.
  • gastric division
    À§ÀÇ ºÐÇÒ.
  • heterotypical division
    ÀÌÇüºÐ¿­.
  • homotypical division
    µ¿ÇüºÐ¿­.
  • lingular division vein
  • longitudinal division
    Á¾ºÐ¿­(ðýÝÂæñ).
  • maturation division
    ¼º¼÷ºÐ¿­(¡­ÝÂæñ).
  • maturation division
    ¼º¼÷ºÐ¿­
  • meiotic division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ).
  • multiple division
    º¹ºÐ¿­(ÜÜÝÂæñ).
  • postreduction division
    °¨¼öÈĺп­
  • prereduction division
    °¨¼öÀüºÐ¿­
  • reduction division
    °¨¼öºÐ¿­
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Diaphragm of nuclear pore
    ÇÙ±¸¸Û°¡·Î¸·
    [¿¾ ¿ë¾î] ÇÙ°ø°Ý¸·
  • Anulus of nuclear pore
    ÇÙ±¸¸ÛµÑ·¹
    [¿¾ ¿ë¾î] ÇÙ°ø·û
  • Nuclear membrane
    ÇÙ¸·
    [¿¾ ¿ë¾î] ÇÙ¸·
  • Nuclear chain fiber
    Çٻ罽±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ¼â
  • Nuclear vesicle
    ÇÙ¼ÒÆ÷
    [¿¾ ¿ë¾î] ÇÙ¼ÒÆ÷
  • Nuclear saccule
    ÇÙÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÇÙ³¶
  • Nuclear saccule
    ÇÙÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÇÙ¼Ò³¶
  • Nuclear bag fiber
    ÇÙÁָӴϱÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ³¶
  • Nuclear phenomena
    ÇÙÇö»ó
    [¿¾ ¿ë¾î] ÇÙ»ó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nuclear cycle
    ÇÙÁÖ±â(ú·ñÎÑ¢)
  • nuclear duplication
    ÇÙº¹»ç(ú·ÜÜÞÐ)
  • nuclear emulsion
    ÇÙ(ú·)¿¡¸ÖÀü
  • nuclear envelope
    ÇÙ¸·(ú·Ø¯)
  • nuclear equivalent
    ÇÙ´çü(ú·Ó×ô÷)
  • nuclear fission
    Çٺп­(ú·ÝÂÖª)
  • nuclear fusion
    ÇÙÀ¶ÇÕ(ú·ë×ùê)
  • nuclear isomer
    ÇÙÀ̼ºÃ¼(ú·ì¶àõô÷)
  • nuclear magnetic resonance
    ÇÙÀÚ±â°ø¸í(ú·í¸ÐïÍìÙ°)
  • nuclear resonance scattering
    ÇÙ°ø¸íºÐ»ê(ú·ÍìÙ°ÝÂߤ)
  • nuclear zone
    ÇÙ¿ª(ú·æ´)
  • small nuclear RNA
    ¼Ò(á³) ÇÙ(ú·)RNA
  • small nuclear ribonucleoprotein
    ¼Ò(á³) ÇÙ(ú·) ¶óÀ̺¸ÇÙ»ê´Ü¹éÁú(ú·ß«Ó±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Hb Hemoglobin; Ç÷»ö¼Ò; 13 - 15 mg%
  1 gm ÆÄ±«½Ã Indirect Bilirubin 40 mg Áõ°¡
  = ...
IFA test Indirect Fluorescent Antibody test
IHA test Indirect Hem-Agglutination test
IBPMS indirect blood pressure measuring system
IC icteric, icterus; immune complex; immunoconjugate; immunocytochemistry; immunocytotoxicity; impedanc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IFA Indirect Fluorescence Antibody
IFAT Indirect Fluorescence Antibody Test
IFA Indirect Fluorescent Antibody
IFA Indirect Fluorescent Antibody Test
IFAT Indirect Fluorescent Antibody Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • indirect pulp therapy
    °£Á¢ Ä¡¼ö Ä¡·á
  • indirect resin
    °£Á¢ ·¹Áø
    ¿­À» °¡Çؾ߸¸ ÁßÇÕ ¹ÝÀÀÀÌ ÀϾ °íüȭµÇ´Â ¼öÁö.
  • indirect retainer
    °£Á¢ À¯Áö ÀåÄ¡
    ÈÄ¹æ ¿¬Àå ±¹¼Ò ÀÇÄ¡¿¡¼­ fulcrum lineÀÇ ¹Ý´ëÂÊ¿¡¼­ Áö·¿´ëÀÇ ÀÛ¿ë¿¡ ÀúÇ×ÇÔÀ¸·Î½á Á÷Á¢ À¯Áö ÀåÄ¡¸¦ µµ¿Í¼­ ÀÇÄ¡ÀÇ Å»¶ôÀ» ¸·¾ÆÁÖ´Â ±¹¼Ò ÀÇÄ¡ÀÇ ÇÑ ºÎºÐÀÌ´Ù.
  • indirect symptom
    °£Á¢ Áõ»ó
    ƯÁ¤ Áúȯ°ú Á÷Á¢ÀûÀ¸·Î °ü°è°¡ ¾ø´Â Áõ»ó.
  • indirect tensile test
    °£Á¢ ÀÎÀå °­µµ ½ÃÇè
  • indirect-direct method inlay
    Á÷Á¢ °£Á¢¹ý Àη¹ÀÌ
    Á÷Á¢¹ý°ú °£Á¢¹ýÀ» º´¿ëÇÏ¿© ¸¸µç Àη¹ÀÌ.
  • mandibular division
    ÇÏ¾Ç ºÐÁö
  • maxillary division
    »ó¾Ç ºÐÁö
  • monocular indirect ophthalmoscope
    ´Ü¾Èµµ»ó°Ë ¾È°æ
  • multiple fission,multiple division
    ´Ù ºÐ¿­
    1°³ÀÇ ¸ð¼¼Æ÷°¡ ÀϽÃÀûÀ¸·Î ´Ù¼öÀÇ µþ ¼¼Æ÷·Î ³ª´©¾îÁö´Â ÀÏ. º¹ ºÐ¿­À̶ó°íµµ ÇÑ´Ù. ¸ðü°¡ 2°³ÀÇ µþ °³Ã¼·Î ³ª´©¾îÁö´Â 2ºÐ¿­¿¡ ´ëÇÏ¿© ÀϽÿ¡ ´Ù¼öÀÇ µþ °³Ã¼·Î ºÐ¿­ÇÏ´Â Çö»óÀ» ¸»ÇÑ´Ù. ¿ø»ýµ¿¹° Æ÷ÀÚÃæ·ùÀÇ Áõ¿ø»ý½Ä µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. Áï, ÇÙ¸¸ÀÌ ºÐ¿­À» µÇÇ®ÀÌÇÏ¿© ´ÙÇÙü°¡ µÈ µÚ¿¡ ¼¼Æ÷ÁúÀÌ ÀÏÁ¦È÷ ºÐ¿­ÇÏ¿© °¢°¢ ÇÙ 1°³¾¿À» ÇÔÀ¯ÇÏ´Â µþ °³Ã¼·Î ³ª´©¾îÁø´Ù.
  • optic nerve division
    ½Ã½Å°æ Àý´Ü
  • net nuclear magnetization
    ÃÑ ÇÙ ÀÚ±âÈ­
  • nuclear
    ÇÙÀÇ, ¿øÀÚ ÇÙÀÇ
  • nuclear antigen
    ÇÙ Ç׿ø
  • nuclear bag fiber
    ÇÙ ³¶ ¼¶À¯
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
division 1. The act of dividing.
2. <zoology> A rank that if treated as a division of a genus or subgenus is deemed to be of subgeneric rank for the purposes of nomenclature.
3. A taxon at the rank of division. The second highest taxonomic classification for the kingdoms Plantae (plants) and Fungi, between kingdom level and class level.
(09 Jan 1998)
division septum <cell biology> The cell wall that forms between daughter cells at the end of mitosis in plant cells or just before separation in bacteria.
(18 Nov 1997)
equatorial division Nuclear division in which each chromosome divides equally.
(05 Mar 2000)
first meiotic division The first of two consecutive divisions of the nucleus of an eukaryotic cell during the process of meiosis. It includes the following stages of meiosis: prophase I, metaphase I, anaphase I, and telophase I.
(09 Oct 1997)
calorimetry, indirect Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange.
(12 Dec 1998)
indirect 1. Not immediate or straight.
2. Acting through an intermediary agent.
Origin: L. Indirectus
(18 Nov 1997)
indirect agglutination Agglutination of particles that have been coated with soluble antigen, by antiserum specific for the adsorbed antigen.
Synonym: indirect agglutination.
(05 Mar 2000)
indirect assay For antibody; an application of the ELISA method in which serum being tested for antibody is added to wells coated with known antigen; presence of antibody bound to the antigen coat can be determined by addition of immunoglobulin-specific antibody to which is linked the enzyme of the indicator system, followed by addition of substrate to the washed aggregate.
(05 Mar 2000)
indirect bilirubin <biochemistry> Free bilirubin that has not been attached to a glucuronide molecule. This results from the rapid breakdown of red blood cells. The haemoglobin molecule is normally converted to bilirubin. Greater than normal values of indirect bilirubin can be seen in erythroblastosis foetalis, haemolytic anaemia, sickle cell anaemia, transfusion reactions, pernicious anaemia and resolution of large haematomas.
(27 Sep 1997)
indirect Coombs' test A test routinely performed in cross-matching blood or in the investigation of transfusion reaction: test for patient's serum is incubated with a suspension of donor erythrocytes; if specific antibodies are present, they become attached to the antigen in donor's cells; after a washing with saline, Coombs' antihuman globulin is added; agglutination at this point indicates that antibodies present in the original test serum had indeed become attached to donor erythrocytes.
(05 Mar 2000)
indirect diuretic A diuretic that acts by increasing cardiac function or by increasing the state of hydration.
(05 Mar 2000)
indirect fluorescent antibody The detection of antibodies to specific antigenic material in the substrate using fluorescent microscopy. Using fluorescent conjugated antibodies which are specific for a particular isotype of antibody, it is possible to distinguish IgG, IgA and IgM isotypes of specific antibodies using indirect fluorescent antibody. This sensitive technique is highly specific in well-trained hands and recent developments in the establishment of internationally recognised standard materials have led to accurate quantitation of antibody concentrations through endpoint titration (the highest serial dilution of specimen at which specific fluorescence remains) and through measuring visual intensity of fluorescence compared to known reference standard material.
(05 Mar 2000)
indirect fracture A fracture, especially of the skull, that occurs at a point not at the site of impact.
(05 Mar 2000)
indirect haemagglutination test A kind of passive agglutination in which erythrocytes, usually modified by mild treatment with tannic acid or other chemicals, are used to adsorb soluble antigen onto their surface, and which then agglutinate in the presence of antiserum specific for the adsorbed antigen.
Synonym: indirect haemagglutination test.
(05 Mar 2000)
indirect immunofluorescence <procedure> A method of immunofluorescence staining in which the first antibody, that is directed against the antigen to be localised, is used unlabelled and the location of the first antibody is then detected by use of a fluorescently labelled antiIgG (against IgGs of the species in which the first antibody was raised). The advantage is that there is some amplification and a well characterised goat antirabbit IgG antibody can, for example: be used against a scarce specific antibody raised in rabbits. The same technique can be used for ultrastructural localisation of the first antibody by substituting peroxidase or gold labelled second antibody.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • indirect fire
    (±º)°£Á¢ Á¶ÁØ»ç°Ý
  • indirect lighting
    °£Á¢Á¶¸í
  • indirect narration
    INDIRECT DISCOURSE
  • indirect object
    (¹®¹ý)°£Á¢ ¸ñÀû¾î
  • indirect primary
    (¹Ì)°£Á¢ ¿¹ºñ ¼±°Å
  • indirect speech
    (¿µ)INDIRECT DISCOURSE
  • indirect tax
    °£Á¢¼¼
  • Nuclear Regulatory Commission
    ¹Ì±¹ÀÇ ¿øÀÚ·Â ±ÔÁ¦ À§¿øÈ¸
  • nuclear
    (»ý)¼¼Æ÷ÇÙÀÇ;ÇÙÀ» Çü¼ºÇÏ´Â;¿øÀÚÇÙ·ÂÀÇ;¿øÀÚ¹«±âÀÇ;ÇÙ¹«±âÀÇ;ÇÙº¸À¯ÀÇ;ÇÙ½ÉÀÇ;ÁÖ¿äÇÑ;ÇÙ¹«±â;ÇÙº¸À¯±¹
  • nuclear bomb
    ÇÙÆøÅº
  • nuclear chemistry
    ÇÙÈ­ÇÐ
  • nuclear disarmament
    ÇÙ±ºÃà
  • nuclear energy
    ÇÙ ¿¡³ÊÁö !
  • nuclear failout
    ÇÙ Æø¹ß¿¡ ÀÇÇÑ ¹æ»ç´É ³«Áø
  • nuclear family
    ÇÙ°¡Á·
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á